Glucagon; Dextrose; Toradol; Zofran Flashcards
Glucagon - Classification
Pancreatic Hormone (Antihypoglycemic Agent)
Glucagon - Mechanism of Action
Stimulates the liver to convert Glycogen to Glucose resulting in an increase in blood glucose levels; Inhibits Glycogen synthesis; Positive inotropic agent
Glucagon - Indications
Hypoglycemia; Beta Blocker Overdose
Glucagon - Contraindications
Hypersensitivity; Insulinoma
Glucagon - Adverse Effects
Hyperglycemia; Nausea; Vomiting; Hypotension; Tachycardia
Glucagon - Dosage
Hypoglycemia: 1mg (IM/IN)
Beta Blocker Overdose: 3-10mg over 3-5 minutes (Followed by infusion at 3-5mg/hr)
Glucose (Dextrose) - Classification
Carbohydrate; Hypertonic Solution
Glucose (Dextrose) - Mechanism of Action
Increases blood glucose levels to be used as energy by the body.
Glucose (Dextrose) - Indications
Hypoglycemia
Glucose (Dextrose) - Contraindications
Intracranial and intraspinal hemorrhage; Increased intracranial pressure; Delirium Tremens
Glucose (Dextrose) - Adverse Effects
Hyperglycemia
Glucose (Dextrose) - Dosage
Various Concentrations (Commonly 25g)
ALS D10: 250mL of 10% Dextrose Solution (25g) IV
ALS D50: 50mL of 50% Dextrose Solution (25g) IV
BLS Oral Glucose: 15g-25g PO
Ketorolac (Toradol) - Classification
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Ketorolac (Toradol) - Mechanism of Action
Prevents the synthesis of Prostaglandins by inhibiting at least two Cyclo-Oxygenase Enzymes. (Exact mechanism of action of NSAIDs is unknown)
Ketorolac (Toradol) - Indications
Moderate to severe pain (Musculoskeletal injury; Migraine; Nontraumatic abdominal / flank / back pain)
Ketorolac (Toradol) - Contraindications
Allergies to NSAIDs; Renal Failure; Active bleeding; Peptic Ulcer Disease; Acute Myocardial Infarction; Patients greater than 65 years of age
Ketorolac (Toradol) - Adverse Effects
Nausea; Vomiting; Constipation; Hypertension
Ketorolac (Toradol) - Dosage
Adult: 15mg (IV/IO) or 30mg (IM)
Pediatric: 0.5mg/kg (IM/IV/IO)
Ondansetron (Zofran) - Classification
Serotonin 5-HT3 Receptor Antagonist (Antiemetic)
Ondansetron (Zofran) - Mechanism of Action
Blocks the Serotonin receptors in the Chemoreceptor Trigger Zone (CTZ) of the Medulla Oblongata; Decreases communication with the vomiting center of the Medulla Oblongata
Ondansetron (Zofran) - Indications
Nausea and vomiting of persons over 12 years of age
Ondansetron (Zofran) - Contraindications
Hypersensitivity
Ondansetron (Zofran) - Adverse Effects
Drowsiness; Hypotension; Serotonin Syndrome; May cause prolonged QT intervals
Ondansetron (Zofran) - Dosage
4mg (Slow IVP/IM/IO/PO)